Skip to main content

Product Launch

Aeonsemi Launches Praxium PHY Family for Physical AI Ethernet

Image
Aeonsemi Launches Praxium PHY Family for Physical AI Ethernet

Santa Clara, Calif. – September 22, 2026 -- Aeonsemi, Inc. has introduced the Praxium PHY family, a line of multi-gigabit Ethernet transceivers delivering data rates up to 10 Gbps in a 6 x 6 mm QFN package for robots, autonomous vehicles and industrial machines.

Praxium cuts power to as low as 350 mW for 10 Gbps sensor links

The chips support IEEE 802.3ch standards for 10GBASE-T1, 5GBASE-T1 and 2.5GBASE-T1 operation, and use Energy-Efficient Ethernet on lower-speed uplinks to reach the 350 mW figure for asymmetric 10 Gbps connections. The family targets cameras, LiDAR, zone controllers and network backbones inside Physical AI systems where component size and power budgets are constrained.

Compugen to Detail COM701 Ovarian Cancer Trial Data at Oct. 5 KOL Event

Image
Compugen to Detail COM701 Ovarian Cancer Trial Data at Oct. 5 KOL Event

Holon, Israel – September 22, 2026 -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) will host a virtual key opinion leader event on October 5, 2026 at 8:00 AM ET, presenting new detail on COM701, its anti-PVRIG antibody candidate for relapsed platinum-sensitive ovarian cancer (PSOC).

Harvard oncologist to preview MAIA-ovarian trial design and timeline

Oladapo Yeku, M.D., Ph.D., FACP, of Harvard Medical School and Massachusetts General Hospital, will join Compugen management to discuss the randomized MAIA-ovarian adaptive platform trial. The study evaluates COM701 as a maintenance therapy in relapsed PSOC patients, with median progression-free survival data from the interim analysis expected by Q1 2027. COM701 has already shown initial anti-tumor activity and a favorable safety and tolerability profile in Phase 1 studies as monotherapy and in combination regimens.

Sealed Air Launches ZeroPrep Pouches to Cut Condiment Prep Time

Image
Sealed Air Launches ZeroPrep Pouches to Cut Condiment Prep Time

Charlotte, N.C. – September 22, 2026 -- Sealed Air Corporation has launched CRYOVAC® brand ZeroPrep hand-dispensing pouches, a pre-filled packaging format designed to eliminate squeeze bottle preparation and cleanup in restaurant back-of-house operations.

Pre-filled pouches replace rigid squeeze bottles in food service kitchens

Each ZeroPrep pouch includes an easy-open seal and a resealable spout that allows one-handed dispensing of condiments and sauces without drips. The pouches are hermetically sealed until first use, reducing contamination risk by removing the step of transferring condiments into secondary containers.

Zocdoc Expands Booking Network to AI Platforms, Search Engines

Image
Zocdoc Expands Booking Network to AI Platforms, Search Engines

NEW YORK – September 22, 2026 -- Zocdoc announced a platform expansion that makes healthcare providers bookable beyond Zocdoc.com through a single connection to its Care Access Network, which already includes Amazon Health AI, Gemini, Yelp, Healthgrades, Blue Shield of California and multiple search engines.

Patients now search for care across a growing number of fragmented channels

A new national Zocdoc survey found that 69% of patients who search for a new doctor check multiple places, from AI platforms and insurance directories to search engines and review sites. More than 1 in 3 patients have switched doctors because scheduling was too difficult, while 43% would consider switching to a provider that is easier to book.

Benzinga News Integrates Into Kinetiq's Markets App Home Feed

Image
Benzinga News Integrates Into Kinetiq's Markets App Home Feed

Detroit – September 22, 2026 -- Benzinga has integrated its real-time news feed directly into the home screen of Markets App: Stocks & Crypto, the trading platform operated by Kinetiq, letting users read market news and execute trades without switching tools.

Benzinga News now surfaces alongside trade commentary in the app's feed

The integration places Benzinga News next to the trade theses and commentary that Markets App users already post and read, allowing a user to see a news article about a held stock, place a trade, and share their reasoning without leaving the app.

Captello Launches Record-Level Revenue Tracking for B2B Events

Image
Captello Launches Record-Level Revenue Tracking for B2B Events

Dallas – September 22, 2026 -- Captello has launched Event Revenue Intelligence, a platform capability that traces closed B2B revenue back to individual badge scans rather than program-wide averages, aiming to close a measurement gap that has left event budgets undefended for decades.

Trade shows drive 33% of new business but 79% of leads get no follow-up

Trade shows generate 33% of new business annually, according to research cited in the Lead Capture Playbook, yet 79% of event leads never receive follow-up, per CEIR data via 391 Advantage. An EMS25 white paper found 58% of event marketers report losing leads to inefficient capture and 47% struggle to integrate event data into CRM systems, while 73% now rank analytics and reporting as the top lead-capture priority.

Echola Launches 800G/1.6T OptiShare Switches for AI GPU Testing

Image
Echola Launches 800G/1.6T OptiShare Switches for AI GPU Testing

San Jose, Calif. – September 22, 2026 -- Echola Systems has introduced two optical test switches, the OPX4D-SM and OPX8D-SM, designed to cut equipment costs for engineers validating AI data center GPU cluster networks running at 800G and 1.6T speeds.

OptiShare switches let one test resource serve multiple devices under test

The OPX4D-SM offers a 1×4 configuration supporting four devices under test (DUTs), while the OPX8D-SM provides a 1×8 configuration for eight DUTs. Custom builds scale up to 1×32, accommodating 32 DUTs. Engineers select one DUT connection at a time for sequential, automated testing, eliminating the need to dedicate costly instruments like bit error rate testers and protocol analyzers to every device.

NWEA Launches Free College-Matching Tool Tied to MAP Growth Scores

Image
NWEA Launches Free College-Matching Tool Tied to MAP Growth Scores

Boston – – September 22, 2026 -- NWEA has released an enhanced free online tool that lets students as young as sixth grade convert their MAP Growth assessment scores into projected ACT and SAT scores and matching college admissions data.

Tool converts middle-school test scores into projected SAT and ACT results

The NWEA College Explorer allows students to enter current MAP Growth scores and see estimated performance on the ACT and SAT, then generates a list of post-secondary institutions that have historically admitted students with similar scores. The organization cited one example: a seventh grader scoring 222 on the fall MAP Growth math assessment is projected to meet the SAT math benchmark expected at most colleges and universities, but fall short of the comparable ACT math benchmark.

Nice Enters European HVM Market With CE-Certified HySecurity Line

Image
Nice Enters European HVM Market With CE-Certified HySecurity Line

London – September 22, 2026 -- Nice has formalized its entry into the European hostile vehicle mitigation (HVM) market, rolling out CE-certified products from its HySecurity division after previously supplying the region only on a project-by-project basis.

Nice Establishes Structured European Route to Market for HySecurity

HySecurity, acquired by Nice in 2016, brings more than 60 years of expertise in hydraulic gate operators and crash-rated barriers for airports, government facilities and data centres. Nice will now support the division with local commercial and technical teams alongside its existing network of installers and system integrators, moving away from ad hoc project sales.

Beactica Starts IND-Enabling Studies for Glioblastoma Drug BEA-17

Uppsala, Sweden – September 22, 2026 -- Beactica Therapeutics AB has initiated IND-enabling studies for BEA-17, a first-in-class oral degrader targeting the epigenetic regulators LSD1 and CoREST, moving the glioblastoma therapy toward first-in-human trials.

Beactica targets a cancer with 15-month median survival and no new treatment in over two decades

Glioblastoma remains the most common and aggressive primary brain tumour, with a median overall survival of approximately 15 months. Standard of care has stayed essentially unchanged for more than 20 years, and immunotherapies successful against other cancers have consistently failed against GBM's immunosuppressive tumour microenvironment.